Objectives-Assessment of the features of primary operable breast carcinomas arising in women known to subsequently develop metastatic disease, to show for which invasive breast cancers earlier detection by mammographic screening is potentially beneficial. These data were applied to a separate series of screen detected cancers. Methods-Features associated with the development of metastatic disease after a previous operable breast cancer were ascertained from examination of histological sections of the initial primary carcinoma and in particular the incidence of nodal positivity and definite vascular invasion. Trends in the frequency of nodal involvement and vascular invasion according to histological grade, invasive size, and tumour type were then examined in a further group of 573 screen detected invasive cancers to predict the likelihood of development of systemic disease in these women. Results-Of 173 women who developed metastatic disease after a previous operable breast cancer, 79 (72%) had nodal metastases and 62 (59%) had definite vascular invasion. A high proportion (84%) had either lymph node metastases or vascular invasion or both. The absence of vascular invasion and nodal involvement in invasive breast cancer indicated a low risk of subsequent development of metastatic disease. In the screen detected group, grade 1 invasive cancers <20 mm in size and grade 2 and 3 cancers <10 mm in size had low rates of nodal involvement and vascular invasion. There was a gradual trend to small size, lymph node negativity, and less vascular invasion when comparing screen detected ductal carcinoma of no special type, tubular mixed carcinoma, and tubular carcinoma. Cancers with a lobular component tended to be larger and more often lymph node positive than ductal and no specific type carcinomas. Conclusions-These data suggest that identification of grade 1 cancers less than 20 mm in size and grade 2 and 3 cancers less than 10 mm in size at screening is likely to be beneficial, with a lower likelihood of developing metastatic disease from these lesions. The detection of tubular mixed carcinomas and ductal carcinomas of no specific type also appears beneficial. However the detection of tumours with lobular features at breast screening does not seem to significantly benefit the patient. (J Med Screen 2001;8:86-90) 
Mammographic screening has been shown to reduce breast cancer mortality. 1-3 However breast screening detects a wide range of breast cancer ranging from low grade ductal carcinoma in situ (DCIS) to high grade invasive cancer. [4] [5] [6] It is an issue of debate which particular subgroups should be identified early to have a significant impact on breast cancer mortality. Some argue that detecting high grade DCIS prevents the development of high grade invasive cancer, 7 8 others that detecting low grade, special type invasive cancers prevents "dediVerentiation" into high grade invasive cancers with a poor prognosis. 9 Some think that detecting high grade invasive cancers less than 10 mm in size has the greatest eVect. 9 This study aimed to identify the incidence of axillary nodal metastasis and vascular invasion in primary operable invasive breast cancers in sections from the initial therapeutic surgical specimen in women who later developed metastases and who will succumb to the disease. This information would ascertain whether the absence of these factors could be used to suggest a good prognosis for screen detected invasive breast cancer. The incidence of these prognostic factors in screen detected invasive breast cancer according to histological grade and size will be shown. This may provide insights into which invasive cancers detected at mammographic screening may result in a reduction in population mortality.
Methods
A database of women who developed metastatic disease from breast cancer at our breast unit has been maintained since 1997. The subgroup of these women who developed metastatic disease after a previous therapeutic operation for primary operable breast cancer constituted study group 1. The vascular invasion and lymph node involvement was ascertained in this group. Only women in whom four or more nodes were retrieved were included in the analysis of the lymph nodes. Women with possible but not definite vascular invasion were counted as vascular invasion negative, as is our routine clinical practice. The histological grade and tumour type were also recorded. Thus the histological features of tumours which subsequently develop metastatic disease were determined. These data were then applied to a group of screen detected cancers, to establish the likelihood of metastatic spread in these lesions.
The 573 women with screen detected invasive breast cancer diagnosed since the completion of the prevalent round of screening (1 January 1993) constitute study group 2. Invasive size, histological grade, histological tumour type, lymph node involvement, and vascular invasion were documented. As in study group 1, only women in whom four or more nodes were retrieved were included in the analysis of lymph nodes and possible but not definite vascular invasion was classified as vascular invasion negative. Analysis was then performed to ascertain the sizes at which diVerent grades of tumours detected at screening have to grow before having high rates of nodal involvement and vascular invasion. The distribution of prognostic features in diVerent tumour types detected at screening was also documented.
Results

STUDY GROUP 1 (METASTATIC CARCINOMA)
Microscopic examination of the primary breast carcinomas of the 173 women in this study group who subsequently developed metastatic disease showed that 16 (9%), 50 (29%), and 107 (62%) were invasive carcinomas of histological grades 1, 2, and 3 respectively. Three of the 16 grade 1 lesions were pure tubular carci-nomas. Seventeen (10% of study group 1) were of tubular mixed type.
In study group 1, 110 women had four or more nodes retrieved at surgical treatment of the primary tumour. Thirty one (28%) had uninvolved nodes (stage 1) and 79 (72%) had nodal metastases (stages 2 and 3). Vascular invasion assessment was available in 105 (95%) of these women. Sixty two (59%) were vascular invasion positive and 43 (41%) had no histological evidence of vascular invasion. Vascular invasion assessment was available in 30 (97%) of the patients with node negative tumours; 13 of these (43%) had vascular invasion and 17 (57%) did not.
Overall, 84% of women who subsequently developed metastases after a primary operable breast cancer excision, in whom nodal and vascular invasion data were available, had lymph node metastases or vascular invasion or both. The prevalence of positive lymph nodes or vascular invasion was not significantly diVerent in grade 1, 2, or 3 primary cancers in women who subsequently developed metastatic disease.
STUDY GROUP 2 (SCREEN DETECTED)
Of the 573 women with screen detected invasive breast cancers (study group 2), 98 (17%) had less than four (uninvolved) nodes retrieved and so were excluded from analysis of lymph nodes, as the negativity of their lymph nodes was deemed to be unreliable. Of the remaining 475 women with screen detected invasive cancer, 136 (29%) had lymph node metastasis. Of the 573 screen detected cancers 98 (17%) had definite vascular invasion identified histologically. There was an increasing frequency of vascular invasion from histological grade 1 (7%) to grade 2 (17%), to grade 3 (27%) carcinomas. Nodal positivity was also uncommon in grade 1 tumours but was higher in grade 2 and 3 cancers (15%, 33%, and 36% respectively, table 1).
Comparison of cancers at first screen (prevalent) with those discovered at subsequent screens (incident) showed that although grade 1 tumours were less commonly detected at incident screens (26% v 35%), those identified at these later screens were more often lymph node negative (9% v 22%). Overall rates of nodal involvement (27% v 31%) and vascular invasion (15% v 21%) were, however, similar at first and subsequent screens (tables 2 and 3).
Grade 1 screen detected invasive cancers under 20 mm in size had low rates of nodal involvement (13%), whereas grade 1 cancers over 20 mm in size (although uncommon), had a 44% rate of nodal involvement. Vascular (7) invasion was uncommon in grade 1 cancers (7%) whatever the size of the tumour (table 4) . A low rate of nodal involvement in grade 2 screen detected invasive cancers was only found in small cancers less than 10 mm in size (19%). Grade 2 cancers 10 mm or larger had high rates of nodal involvement (38%). Vascular invasion in grade 2 cancers was uncommon in lesions 15 mm in size or less (8%) but was found in 33% of grade 2 cancers greater than 15 mm (table 5) .
Histological grade 3 invasive cancers less than 10 mm in size were rarely lymph node positive (5%) and also seldom showed vascular invasion (11%). Grade 3 cancers between 10 and 15 mm in size showed rates of lymph node involvement of only 26% but vascular invasion was more commonly seen (23%) than in the grade 1 or 2 cancers of comparable size. Grade 3 cancers over 15 mm in size showed high rates of nodal involvement (48%) and grade 3 cancers over 20 mm also showed high rates of vascular invasion (41%, table 6).
Comparison of the relation between tumour type and the features of size, nodal involvement, and vascular invasion was then undertaken (table 7) to find whether patients with any particular tumour type might gain significant benefit from detection at mammographic screening. There was a gradual trend to detection at smaller size, with lymph node negativity and the absence of vascular invasion when comparing ductal carcinoma of no special type, tubular mixed carcinoma, and tubular carcinoma. However lobular carcinomas and carcinomas of mixed pattern but containing a lobular component tended to be larger and more often lymph node positive than tumours of ductal no specific type.
Discussion
The mechanism by which mammographic screening reduces breast cancer mortality is a subject of debate. It is well recognised that screening detects many low grade, special type invasive cancers, 5 6 and that such tumours have an excellent prognosis. Some argue that such tumours are so indolent that they may never have presented clinically or have threatened life. It has, however, been proposed that a proportion of low grade invasive tumours may dediVerentiate over time into more aggressive, less well diVerentiated tumours. 9 If this is true, identification and removal of such cancers when low grade will avoid such progression. Others argue that it is the detection of high grade invasive cancers while small by which screening reduces breast cancer mortality. In support of this, it has been shown that histological grade 3 invasive cancers detected when less than 10 mm in the Swedish two counties trial have an excellent prognosis, 9 although it is well recognised that high grade invasive cancer of large size has a dismal outlook.
Both nodal and vascular invasion have previously been shown to be powerful independent prognostic factors in patients with invasive breast carcinoma. [9] [10] [11] [12] [13] [14] This study has also shown that 84% of the subgroup of women with primary operable invasive breast cancer who subsequently develop metastatic disease, had involved lymph nodes, or vascular invasion, or both at the time of initial surgery. This finding is consistently present whatever the histological grade of the primary tumour. Indeed the absence of involved lymph nodes and vascular invasion indicates a low risk of developing metastatic disease and thus of dying from systemic breast cancer. In the second portion of the study we applied these data to a group of screen detected cancers to find which subgroups of screen detected breast cancer had a low incidence of nodal disease and an absence of vascular invasion and may thus benefit from early detection. The groups selected for analysis were those based on the intrinsic morphological features of the invasive tumour (histological grade and tumour type) at diVering sizes. Of the well differentiated, less intrinsically aggressive (grade 1) carcinomas, only those over 20 mm in size had a high risk of lymph node positivity. Nevertheless a total of 9% of primary breast cancer that metastasised were grade 1 lesions. Thus grade 1 invasive cancers when large can, and do, threaten life. Detection of these lesions when small should therefore not be seen as overdiagnosis and these data suggest that the detection of grade 1 invasive cancers under 20 mm in size by mammographic screening is likely to produce a mortality benefit.
The low rates of nodal positivity and vascular invasion of screen detected grade 2 invasive cancers less than 10 mm in diameter indicate the value of their detection at this size. Histological grade 2 cancers between 10 and 15 mm had moderately high rates of nodal involvement but low rates of vascular invasion. The benefit of detecting grade 2 cancers between 10 and 15 mm in size is therefore less clear. Larger grade 2 cancers (over 15 mm) already had high rates of nodal involvement and vascular invasion at time of diagnosis and their detection by mammographic screening is therefore unlikely to be of significant benefit. A low rate of both nodal positivity and vascular invasion was found in screen detected grade 3 invasive cancers less than 10 mm in size suggesting that detection of these small high grade tumours is valuable, especially as larger grade 3 invasive cancers have such a poor prognosis. Indeed grade 3 cancers over 20 mm in this series had high rates of nodal positivity and vascular invasion indicating that their detection is unlikely to be beneficial. The moderate rates of nodal involvement and vascular invasion in grade 3 cancers of intermediate size (10-20 mm) suggests that their detection is less likely to be beneficial than detection of these tumours when small.
The detection by breast screening of carcinomas with tubular features is aided by the high frequency of spiculation seen at mammography. 15 It is well recognised that screen detected pure tubular carcinomas have good prognostic features. This is confirmed by the finding in this study that there was a very low incidence of pure tubular cancers in the group of women who subsequently developed metastatic disease (three of all of the 173 (2%) patients, three of the 16 (20%) grade 1 lesions). This suggests that overdiagnosis may be occurring in at least a proportion of these tumours. The value of detecting pure tubular cancer at screening is therefore only likely to be of benefit if a proportion of tubular cancers dediVerentiate if left in the breast. Whether they may do so or not is not clear and the data presented here cannot answer that question. In general, screen detected carcinomas of tubular mixed type similarly have good prognostic features but overdiagnosis does not seem to be a notable problem with such tumours as 10% of cancers that metastasize are of tubular mixed type indicating a potential to threaten life.
Ductal carcinomas of no specific type have time dependent prognostic factors (size and lymph node stage) that are, in general, moderately good, suggesting that their detection at screening is eVective. However, lobular cancers and lobular mixed cancers are larger and more often lymph node positive at mammographic detection and thus identification of cancers with a lobular component by breast screening is less likely to be beneficial. This contrasts with the symptomatic population, where patients with lobular carcinoma have a better prognosis than those with ductal tumours or tumours of no specific type. 16 It is also recognised that mammographic detection of lobular cancer is diYcult; they are more commonly seen on only one mammographic view and less often contain calcification compared with ductal no specific type carcinomas. 17 In conclusion, the absence of definite vascular invasion and of nodal involvement in a primary invasive breast cancer indicates a low risk of subsequent development of metastatic disease and death. Application of these data to screen detected invasive carcinomas shows that concentration should be focused on the detection of grade 1 cancers less than 20 mm and grade 2 and grade 3 cancers less than 10 mm in size to obtain benefit. The value of detecting grade 2 and grade 3 invasive cancers between 10 and 15 mm in size is unclear. Once a grade 2 or 3 invasive carcinoma reaches more than 15 mm in size, detection by screening is unlikely to aVect outcome. Patients may also not benefit significantly from the mammographic detection of pure tubular carcinoma (which may represent a degree of overdiagnosis) and tumours with a lobular component (which are already of lymph node stage and size which indicates a poor outcome).
